News & Press Releases
Filter by:
Will FDA Adverse Event Data Release Mean More Lawsuits?
January 18, 2017
In this Law360 feature article, Joanne Hawana and Dan Herling discuss the release of data regarding adverse events received by the FDA’s Center for Food Safety and Applied Nutrition, whether the timing of the release matters, and what greater AER transparency means for litigations risks.
EB-5 Update Could Pump The Brakes On Investor Numbers
January 18, 2017
This Law360 article discusses contentious updates to the EB-5 visa program, which gives green cards to foreign residents who invest heavily in U.S. businesses.
The FDA targeted DTC, video, unapproved drug promotion in 2016
January 18, 2017
This article, published in Medical Marketing & Media, addresses the FDA’s new approach to regulating drugmakers’ advertising and promotion. Mintz FDA team members Bethany Hills and Joanne Hawana offer insight.
Health Care Enforcement Review And 2017 Outlook: Part 2
January 17, 2017
Three attorneys from Mintz author the second installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.
Mintz Expands National IP Litigation Capabilities with Addition of Top Silicon Valley Attorney
January 17, 2017
Mintz has bolstered its nationally recognized, bicoastal Intellectual Property Practice with the addition of veteran Silicon Valley attorney Stephen J. Akerley, who will serve as a Member in the San Francisco office.
USCIS Parole Rule: A Practical Solution For Entrepreneurs
January 17, 2017
Susan Cohen authors this Law360 column addressing the U.S. Citizenship and Immigration Services publishing a rule expanding immigration regulations regarding the government’s parole authority.
